iPSC-Derived Hepatocytes Like Cells – YBLiHepato

Choose the Best Products for Your Unique Needs




iPSC-Derived Hepatocytes Like Cells – YBLiHepato

YBLiHepato, our iPSC-derived hepatocytes, present a compelling profile of features tailored for a wide range of applications. These versatile cells exhibit heightened sensitivity to hepatotoxic compounds, making them a valuable asset in drug toxicity studies. They actively engage in LDL uptake, confirming the presence of intact LDL receptors vital for lipid metabolism. Furthermore, YBLiHepato showcases functional maturation through active urea production, faithfully mimicking authentic hepatocyte behavior. The preservation of Cytochrome P450 (Cyp) activity, as highlighted by LCMS/MS analysis, ensures their reliability in drug metabolism and safety assessments. RT-qPCR analysis emphasizes the expression of key hepatic markers related to maturation, transport, and lipid metabolism. YBLiHepato emerges as a versatile and dependable choice for research spanning hepatotoxicity, drug metabolism, and hepatic research

Request Quote
YBLiHepato – Release Criteria

Heading 1

Heading 2

Heading 3

Heading 4

Heading 5
Heading 6

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Block quote
Image caption

Ordered list

  1. Item 1
  2. Item 2
  3. Item 3

Unordered list

  • Item A
  • Item B
  • Item C
Text link

Bold text




Download Datasheet
Download Datasheet
Refer Datasheet

Similar to 

iPSC-Derived Hepatocytes Like Cells – YBLiHepato

No Similar Products Found